Pls refer the attachment
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vijaya Diagnostic Centre Ltd's Board Meeting on May 07, 2026 approved audited financial results for Q4 and FY 2026, recommended a final dividend of ₹2 per share (200% on ₹1 face value) subject to shareholder approval at AGM, and announced record date will be declared later. The Board granted 1,79,500 ESOPs to employees at ₹784 per option (average of last 3 months price with 20% discount) under VDCL ESOP Plan 2018. Independent Director Dr. D Nageshwar Reddy will not seek re-appointment for a second term from May 25, 2026 due to pre-occupation. The company also approved acquisition of MRI, EEG and NCV Services Business from its wholly-owned subsidiary Medinova Millennium MRI Services LLP for approximately ₹4.20 crore, expected to complete within 3 months. M/s. Santhosh & Associates were re-appointed as Cost Auditors for FY 2026-27.
The dividend recommendation signals confidence in the company's financial health. The ESOP grant aligns employee interests with shareholders. The business acquisition from the subsidiary is a related party transaction that consolidates operations and may drive future growth.